Trader sentiment for U.S. measles cases in 2026 leans toward elevated risk, driven by 2024's record 223 confirmed cases—the most since elimination in 2000—according to CDC surveillance, fueled by declining MMR vaccination rates hovering at 93% nationally, below the 95% herd immunity threshold. Vaccine hesitancy in Orthodox Jewish and other communities, plus importation from endemic regions like Europe and Asia per WHO data, sustains outbreak potential. Current market-implied odds reflect this momentum, but uncertainty looms from improving school mandates and potential federal campaigns. Traders should monitor CDC's weekly case updates through 2025 and Q1 2026 data releases, which define resolution via annual totals exceeding historical baselines of under 100.
Experimental AI-generated summary referencing Polymarket data · UpdatedMeasles cases in U.S. in 2026?
Measles cases in U.S. in 2026?
$7,367,255 Vol.
↑2k
98%
↑3k
84%
↑4k
66%
↑5k
39%
↑7.5k
22%
↑10k
13%
↑12.5k
14%
$7,367,255 Vol.
↑2k
98%
↑3k
84%
↑4k
66%
↑5k
39%
↑7.5k
22%
↑10k
13%
↑12.5k
14%
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Market Opened: Dec 1, 2025, 12:56 PM ET
Resolver
0x65070BE91...Resolver
0x65070BE91...Trader sentiment for U.S. measles cases in 2026 leans toward elevated risk, driven by 2024's record 223 confirmed cases—the most since elimination in 2000—according to CDC surveillance, fueled by declining MMR vaccination rates hovering at 93% nationally, below the 95% herd immunity threshold. Vaccine hesitancy in Orthodox Jewish and other communities, plus importation from endemic regions like Europe and Asia per WHO data, sustains outbreak potential. Current market-implied odds reflect this momentum, but uncertainty looms from improving school mandates and potential federal campaigns. Traders should monitor CDC's weekly case updates through 2025 and Q1 2026 data releases, which define resolution via annual totals exceeding historical baselines of under 100.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions